Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Events

26 Oct 2026 - 29 Oct 2026
16 Nov 2026 - 19 Nov 2026

Research Initiative to Improve Cancer Diagnosis, Therapy

By HospiMedica staff writers
Posted on 02 Mar 2005
The University of Pennsylvania (Penn; Philadelphia, PA, USA) has recently been chosen to become a member of the U.S. More...
National Cancer Institute's (NCI) Mouse Models of Human Cancers Consortium (MMHCC; Frederick, MD, USA).

As a member of the Consortium, the Penn team of scientists' strategy is to develop conceptual and technical approaches for determining the processes of breast tumor progression and metastasis. To achieve this goal, they will utilize a wide range of state-of-the-art molecular and cellular imaging methods to assess a series of novel, genetically engineered mouse models of breast cancer. "This type of endeavor requires a group of scientists with a tremendous breadth of knowledge and expertise, which this grant has allowed us to assemble,” stated Lewis A. Chodosh, M.D., Ph.D., vice chair, department of cancer biology, at the Abramson Cancer Center at Penn. Dr. Chodosh.

The Penn MMHCC team will specifically use a wide-ranging array of advanced technologies including magnetic resonance imaging (MRI), positron emission tomography (PET), single photon emission computed tomography (SPECT), magnetic resonance spectroscopy (MRS), and ultrasound to visualize and track tumor cells in living animals from their origins to their gradual progression to distant metastasis and recurrence.

The technology will also be utilized to evaluate tumor response to therapy and to predict clinical outcomes. The mouse models to be used in this project are distinctive in that the investigators can follow the complete natural history in each animal--from the initial onset to response to therapy, tumor dormancy, and ultimately, metastasis and recurrence.

Advanced stages of tumor progression, typified by resistance to therapeutic drugs, metastasis, and tumor recurrence, are responsible for most of cancer deaths. Whereas tumor progression, however, comprises a problem of incredible clinical significance, the underlying processes are basically unknown. Understanding more about the physiologic and molecular events that add to this mechanism is a crucial priority in cancer research.





Related Links:
The University of Pennsylvania
MMHCC

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Gold Member
Blood Gas Analyzer
i-Check200
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image Credit: Adobe Stock

Noninvasive Brain-Computer Interface Enables Responses in Some Unresponsive ICU Patients

Cognitive motor dissociation occurs when patients retain signs of consciousness but cannot move or speak to communicate. In the ICU, this hidden consciousness can be difficult to distinguish from coma... Read more

Surgical Techniques

view channel
Image: Half-matched bone marrow transplant expands access to curative treatment for children and young adults with severe aplastic anemia. (Photo courtes of Margarita Dionysiou using Bio Render)

Half-Matched Family Donors Could Expand Transplant Access for Severe Aplastic Anemia

Severe aplastic anemia is a rare, life-threatening disorder in which the bone marrow fails to produce enough healthy blood cells, leaving children and young adults vulnerable to anemia, infection, and bleeding.... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.